Pantoprazol I.V. Reig Jofre (Pantoprazole)

Pantoprazole, the active ingredient in Pantoprazol I.V. Reig Jofre, is a proton pump inhibitor presented as an intravenous solution for parenteral use. It reduces gastric acid secretion and is employed in the management of acid‑related gastrointestinal conditions in hospitalised patients. GNH USA supplies Pantoprazol I.V. Reig Jofre as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

GNH USA supplies Pantoprazol I.V. Reig Jofre as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Pantoprazole is a proton pump inhibitor used to manage conditions involving excess gastric acid secretion. - Gastro‑esophageal reflux disease (GERD): provides relief of heartburn and promotes healing of erosive esophagitis. - Peptic ulcer disease: supports ulcer healing and reduces risk of recurrence. - Zollinger‑Ellison syndrome: controls hyper‑secretion of gastric acid in this rare endocrine disorder. - Prevention of stress‑related mucosal damage: reduces incidence of gastrointestinal bleeding in critically‑ill patients.

Pantoprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: typically self‑limiting. - Nausea: occasional and transient. - Abdominal pain: mild discomfort. - Flatulence: excess gas. - Constipation: occasional bowel habit change.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis risk. - Acute interstitial nephritis: renal inflammation. - Severe hypersensitivity reactions: rash, angioedema, anaphylaxis. - Hepatotoxicity: elevated liver enzymes. - Low magnesium levels: hypomagnesemia with prolonged use. - Bone fractures: increased risk with long‑term therapy.

Pantoprazole should be used with consideration of patient‑specific factors and monitoring requirements. - Renal impairment: dose adjustment may be required. - Hepatic impairment: use with caution in severe liver disease. - Elderly patients: monitor for electrolyte disturbances. - Concomitant use with clopidogrel: may reduce antiplatelet effect. - Pregnancy and lactation: assess risk‑benefit before use. - Store at 2-8°C: keep refrigerated; protect the solution against light and do not freeze.

Pantoprazole may interact with several medications, influencing their absorption or activity.

Major Interactions (Avoid): - Clopidogrel: reduced efficacy . - Atazanavir: decreased absorption. - Dasatinib: lowered plasma levels.

Moderate Interaction ​​   ​  : - Warfarin: potential INR‑increase . - Phenytoin: altered metabolism . - Ketamine      t   t  ",